Curcumin enhances the synergistic potential of paclitaxel, reduces cancer cell viability, tumour volume and drug resistance in different cancers: systematic review and meta-analysis

To treat diseases such as cancer, conventional Paclitaxel (PTX)-based treatment regimens are becoming less effective due to the development of resistance. In this respect, the phytomolecule curcumin, which has ethnopharmacological significance in traditional South Asian remedies such as Ayurveda and traditional Chinese medicine, was investigated as a promising chemosensitising and synergistic partner of Paclitaxel.